Virbac has been granted a Limited Marketing Authorisation in the UK for its Gudair vaccine, indicated for the active immunisation of sheep and goats against Mycobacterium avium subspecies paratuberculosis (MAP).
MAP is the causal organism for Johne's Disease, a chronic infection of the intestinal system for which there is no cure.
According to Virbac, Johne's Disease enters most flocks following the introduction of infected stock, often breeding rams, bought at markets without checks on disease provenance. It is then spread by the faeces of often apparently healthy animals but which can contain huge numbers of MAP. The main clinical sign is a thin ewe resulting in poor productivity followed by inevitable death. It can be passed between sheep and cattle.
Ovine Johne's Disease (OJD) in sheep is widespread in Australia where annual death rates of up to 17% have been seen in infected flocks. Virbac says that trials conducted there have demonstrated that vaccination with Gudair can reduce the number of deaths due to OJD by 90% and reduce the numbers of OJD-causing organisms excreted in sheep faeces by 90%.
Ken Sibley MRCVS, Technical Advisor at Virbac says that the number of infected flocks in the UK is unknown and the disease often remains undiagnosed: "Johne's Disease can be a significant cause of loss in infected sheep flocks because of reduced productivity and high culling rates. Vaccination provides the only possible assurance when sourcing sheep from potentially infected flocks and will help to reduce losses from the disease should a farmer inadvertently introduce sheep into an infected flock.
"Lambs identified as replacements should generally be vaccinated between 4 and 16 weeks of age, subcutaneously behind the ear. Sheep over 16 weeks of age can also be vaccinated as this will reduce shedding of organisms in infected animals while bought-in replacements can be vaccinated on arrival at the farm. Sheep require only one vaccination for their lifetime.
"Following its success in Australia, we are delighted to be able to offer Gudair to veterinary surgeons in the UK."
For further information, contact your Virbac territory manager or call: 01359 243243
Schering-Plough, is to launch Zylkene, a new product to help manage stress in cats and dogs at BSAVA Congress this April.
Zylkene is a globally patented bioactive decapeptide derived from the milk protein casein. The company says that it will provide cat and dog owners with a proven alternative to managing stress in their pets and help to manage many common behavioural problems.
Zylkene will be available in 75mg, 225mg and 450mg capsules, which can be given whole or opened and mixed with food or a treat. The initial period of use is 1-2 months, and can be repeated if necessary.
For further information, please contact your local Schering-Plough or Intervet representative on 01895 626 000.
The re-categorisation means veterinary practices can sell the topical parasiticides to ‘walk-in clients’ without the need of a prescription.
Andrew Fullerton, veterinary surgeon and product manager at Ceva Animal Health, said: “The new NFA-VPS category for Vectra 3D spot-on solution for dogs and Vectra Felis 423mg/42.3mg spot-on solution for cats provides veterinary practices with greater flexibility to sell easy-to-use, fast and effective parasite prevention and treatment without a prescription."
For more information, contact your Ceva Animal Health account manager or email cevauk@ceva.com.
The British Veterinary Association's Animal Welfare Foundation has produced an online advice leaflet to guide veterinary surgeons through the possible scenarios in the consulting room.
'The practical and legal approach to the docked puppy' leaflet answers questions like:
Introducing the leaflet BVA AWF Chair Tiffany Hemming said: "With such complex and varying laws on tail docking of dogs this leaflet provides clear guidance for vets on how to handle the first consultation with a docked puppy.
"The leaflet includes an easy to follow flow-chart and aims to help vets tackle the subject without alienating their clients."
You can view the leaflet here.
‘Is neutering dogs doing more harm than good?’ (BVA Congress Theatre, Thursday 16th November 2023 at 10.30am), will explore the latest research into the science of neutering and its impact on dog health and welfare, particularly on behaviour, and will also consider the role of non-surgical alternatives.
The session will be chaired by BVA President Dr Anna Judson, joined by:
The BVA says statistics from its Voice of the Veterinary Profession survey show that among clients who chose to neuter their dogs last year, only 6% picked non-surgical options.
Awareness of these options is low, with vets reporting that 9% of their clients had requested information about non-surgical options when considering neutering, such as sustained-release implants to suppress testosterone production in male dogs.
Among those who considered non-surgical options, clients cited the cost and need for repeat treatments as their main concerns (mentioned by 67% and 58% of vets, respectively), followed by individual variation in the effect and duration of non-surgical alternatives (22% of vets).
Anna said: “Canine neutering is a firmly established part of preventive pet healthcare in the UK, but it is also very much a live discussion within the veterinary profession, with a healthy ongoing debate around its merits and risks, based on evolving evidence.
"BVA’s survey shows low awareness among clients about all available neutering options for their pets, with only a tiny percentage choosing to go down the non-surgical route.
“Our BVA Congress discussion will offer vet professionals in small animal practice insight into the latest research on neutering, including potential longer-term impacts on a dog’s health and behaviour, and views on what that might mean for how vets discuss neutering options with clients.
"The panellists will also share useful tips on how to deal with clients’ questions about surgical and non-surgical options for their pets.”
https://bvajournals.onlinelibrary.wiley.com/toc/20427670/2023/193/S1
Novartis Animal Health UK Ltd has announced the launch of CLiKZiN Pour On for sheep, a short meat withhold period (MWP) product that can be used throughout Spring and Summer for the prevention of blowfly strike in sheep and lambs.
CLiKZiN is a ready-to-use water-based product that protects sheep for eight weeks, and has a meat withhold period of seven days. The product is a line extension of CLiK which offers a longer period of protection at 16 weeks and has a longer withhold period of 40 days. Novartis says that used in conjunction with CLiK, CLiKZiN offers versatile protection throughout the year.
The launch of CLiKZiN comes at the same time that Vetrazin has been reformulated, resulting in a longer meat withhold period for sheep treated with the product.
Thomas Tiley MRCVS from Novartis Animal Health said: "Farmers need reliable protection from the repugnant threat of blowfly strike. CLiKZiN provides eight weeks blowfly prevention together with the trusted performance and safety record associated with CLiK. It also offers the greater flexibility of a seven day meat withhold.
"This makes CLiKZiN ideally suited for a variety of production schedules and stock including lambs for slaughter and pre-shearing ewes."
Blowfly strike can be devastating to sheep, causing severe impact on the welfare of the animal. Within days of a blowfly laying its eggs, clinically normal sheep can be afflicted with flesh eating maggots. This makes prompt and effective treatment critical.
National Sheep Association Chief Executive Peter Morris said: "Fly strike is a terrible burden to the sheep industry both in terms of the welfare of the sheep and economically.
"Having a product available that gives effective prevention against fly strike whilst at the same time having a withdrawal period which does not impinge on the ability of the sheep farmer to market lambs is very welcome. The sheep farmers' armoury against the every day afflictions which affect sheep has been significantly enhanced."
The patient was a four-year-old Labrador called Vinny who, in 2019, became the first dog in the UK to receive a BioMedtrix canine ankle replacement system, implanted by Wear's Head of Orthopaedic Surgery, RCVS Specialist Neil Burton, assisted by Maciej Krukowski.
That first surgery, on Vinny’s right ankle, was successful. However, two years later he needed similar treatment to his left leg.
Neil said: “Vinny first presented to us at Wear Referrals in 2019 with hind limb lameness.
“He was diagnosed with osteoarthritis in his hock joints bilaterally due to a developmental condition called osteochondrosis of the talus causing him ongoing pain and lameness. We operated on the right ankle, with Vinny becoming the first dog in the UK to have this ankle replacement system placed.
“Vinny was significantly more comfortable on this limb postoperatively but his lameness progressively worsened in the left hind limb. The decision was made to perform the same surgery on the left ankle, making Vinny the first dog in the world to have this surgery performed bilaterally.
“Vinny has made another fine recovery from surgery and is now off medication, meaning he can exercise unrestricted and pain-free without a lifetime reliance on painkilling drugs.
“For our team at Wear to be able to offer him this pioneering surgery has been a great opportunity. He’s now a unique case, being both the first UK recipient of this BioMedtrix joint replacement as well as the world's first bilateral ankle replacement with the same system.”
For more information, visit www.wear-referrals.co.uk.
Policyholders will get unlimited access to Joii Pet Care’s video consultations with UK veterinary surgeons, which usually cost £24 per call.
Pet owners with Asda Money pet insurance will also be able to access Joii Pet Care’s symptom checker, which is designed to help pet owners pinpoint issues from their home.
Paul Hallett, co-founder of Vet-AI, said: “We’re delighted to announce this major partnership, which completely opens up access to professional vet care for thousands of pet parents who will benefit hugely from accessing regular, preventative veterinary care from the comfort of their homes.
“Many pet owners are now facing high vet bills and difficulties accessing in-practice veterinary care.
"Both Markerstudy Broking and Asda Money share our commitment to put animal welfare first, and collectively we’ll ensure more owners have easily accessible choice to receive the very best care for their pets.”
Clomicalm contains Clomipramine hydrochloride, a broad-spectrum tricyclic antidepressant that inhibits the neuronal reuptake of serotonin and norepinephrine. A non-sedative, Clomicalm is used in combination with behavioural modification techniques to help separation anxiety.
Itrafungol is an oral solution containing Itraconazole for the treatment of ringworm in cats, administered orally directly into the mouth by means of a dosing syringe.
Both Clomicalm and Itrafungol are available to order from the veterinary wholesalers.
For more information, speak to your Virbac Territory Manager.
The campaign comprises a series of short videos featuring equine behaviourist Gemma Pearson MRCVS. The videos demonstrate quick and simple ways of teaching horses to be quiet, relaxed and safe for injections, clipping, worming, examinations and other veterinary procedures.
Equine practices can share the video links with clients here.
According to a paper published in the journal Equine Veterinary Education in January, an equine vet may expect to sustain between seven and eight work-related injuries that impede them from practicing, during a 30-year working life.1
This is far a higher figure than other civilian occupations such as the construction industry, prison service and the fire brigade.
Bruising, fracture and laceration to the leg or the head were the most common injuries reported with the main cause being a kick with a hind limb. Nearly a quarter of these reported injuries required hospital admission and 7% resulted in loss of consciousness.
David Mountford, CEO at BEVA said: "Many accidents reportedly occur when vets are trying to work with horses who have learnt to avoid examination or treatment and where handlers are not in full control. Gemma’s work at the Royal (Dick) School of Veterinary Studies and her amazing videos show how a little preparation can have a big impact on horse, owner and vet safety.”
David Catlow, Blue Cross director of clinical services, said: "These videos are a superb resource to help with behaviour training in horses and to help them remain calm and manageable in all sorts of circumstances. Time spent on behaviour training of horses, using positive reinforcement methods such as these, is time well spent for everyone’s safety. Blue Cross invests a great deal of time in behaviour training on the horses we rehome, and it works."
The seven practical videos cover how clients can train and prepare their horse for:
David Mountford added: "These videos make interesting viewing for vets as well as horse owners and build on Gemma’s eBEVA webinar "Practical Equine Behaviour" and the Guidance on Managing Equine Risks that BEVA has produced.”
You can watch the videos here.
Photo: Equine vets Malcolm Morley and Gemma Pearson
At present veterinary surgeons must destroy Schedule 2 controlled drugs in the presence of and directed by either an inspector appointed under the Veterinary Medicines Regulations, another veterinary surgeon independent of the practice where the destruction takes place, or a person legally authorised to witness the destruction of controlled drugs such as a Police CD Liaison Officer (CDLO).
This is something which may be helped by the launch of VetSurgeon Connect, a new map-based service on VetSurgeon.org designed to help members of the profession collaborate in a wide range of areas, including controlled drug disposal. VetSurgeon Connect is expected to launch next week.
Meanwhile, the VMD notes that there is a shortage of CDLOs and there are areas of the country where there are no local inspectors, or independent vets who can perform the task. Hence the survey to reveal the size of the problem.
The survey, which should take no more than 15 minutes, is open to all UK registered veterinary surgeons and closes on the 6th June. Here's the link: https://www.surveymonkey.co.uk/r/SHKTBYH
Any questions about the survey can be directed to: the VMD legislation team on 01932 338316 or controlleddrugssurvey@vmd.defra.gsi.gov.uk
The company says Taurador Pour-on provides a stress-free, easy to use treatment, with persistent activity against a large number of cattle parasites, therefore ensuring effective coverage over long periods of the grazing season.
Matthew Swanborough BVSc MRCVS, Veterinary Advisor for Norbrook, said: "The farming industry will be aware that heavy worm burdens can significantly affect the health and productivity of cattle, potentially as much as £100 per head of cattle. We cannot simply ignore these parasites but we must tackle them responsibly. A comprehensive worming strategy is a vital component of any animal health plan, which should be composed of management strategies and any necessary anthelmintic treatments."
Norbrook highlights the product's efficacy against the gutworms Osterstagia osterstagi, Cooperia oncophora and lungworm, Dictyocaulus viviparous, with persistent action against these parasites for 35 days, 28 days and 42 days respectively.
Doramectin, the active ingredient in Taurador, is an anthelmintic belonging to the macrocyclic lactones (3-ML) group, along with ivermectins. Norbrook says both compounds share a wide spectrum of antiparasitic activity and produce a similar paralysis in nematodes and parasitic arthropods.
Dr Leigh Sullivan, Norbrook Large Animal Product Manager, said: "Taurador is the company’s thirteenth new product introduction in the last four years and it is a significant addition to our portfolio. Internal parasites such as gutworms and lungworm can have a serious impact on animal health and welfare, as well as financial implications for farmers, so it is great to be able to provide another product to help reduce the economic impact of these parasites."
Taurador is available in three different pack sizes (1L; 2.5L and 5L) and an appropriate dosing applicator is also available.
Euthasol vet is presented as a clear blue liquid, licensed for intravenous, intracardial and intraperitoneal usage. A dose of 140 mg/kg (equivalent to 0.35 ml/kg) is considered sufficient for all licensed routes of administration.
Euthasol vet comes in vials of 100ml and has a 28 day broached shelf life.
Dechra Brand Manager Claire Morgan said: "Choosing the correct product for euthanasia is vital for veterinary professionals and Euthasol vet offers a highly effective solution.
"The intravenous route of administration should be the route of choice. Where intravenous administration is impossible, the product may be administered via the intracardiac route in all named species.
"Euthasol's versatility in terms of the range of species in which it is licensed for use, coupled with its 400 mg/ml concentration, is set to make it a popular choice in practice."
For more information, visit www.dechra.co.uk
The charity launched the 'Cat Friendly Clinic' accreditation scheme in 2012, in order to raise standards and reduce the stress experienced by cats (and consequently their owners) when visiting clinics.
In order to be accredited as a Cat Friendly Clinic, a clinic must not only meet high standards of cat care in terms of facilities and equipment, but staff must also demonstrate an understanding of the needs and behaviour of cats and put in place measures to ensure that visits to the clinic are more cat-friendly.
In the six years since its inception, the scheme has become a well-recognised standard in feline veterinary care, with accredited clinics all over the world.
The Classic Animal Hospital in South Korea (wow, see the architects' photos here), was founded in September 2017 and consists of three vets, eight nurses and three receptionists. Open 24 hours a day, 365 days a year, the clinic's goal is to "provide outstanding veterinary care using the most advanced medical techniques and equipment in an environment that is both comfortable and welcoming for owners and their loved companions’. Currently, about 30% of the clinic’s clients are cats, and this percentage is continuing to grow.
Park Sungwon, owner of the clinic and Chief of Surgery, said: "Since more and more Koreans are having cats as their companion animals, there is growing interest in the Cat Friendly Clinic programme. So many veterinarians who have just started or want to start their own clinic share information about becoming a Cat Friendly Clinic. I also found out about the Cat Friendly Clinic scheme on the vet internet community. When I decided to open my clinic, I planned to become a Cat Friendly Clinic. So I took ISFM’s requirements into consideration when I designed my clinic."
When asked what cat owners think of the clinic’s Cat Friendly status, Park said: "They are very satisfied with our separated, quiet, cat-only waiting area and large hospitalisation facilities. They think that their cats definitely feel more comfortable at my clinic than they feel at other clinics in my town."
Sarah Endersby, International Cat Care’s Veterinary Development Manager, said: "We are delighted to have accredited the 1000th Cat Friendly Clinic. It is fabulous to know that many veterinary clinics around the world are thinking about how they can make feline visits less stressful, benefitting not only the cats themselves, but their owners and the veterinary team. We have many clinics looking to become a Cat Friendly Clinic, so the community is growing quickly - hopefully we will be welcoming the 2000th clinic in the not too distant future!"
To find out more about the Cat Friendly Clinic scheme, visit catfriendlyclinic.org.
The scheme is supported by six official partners: Boehringer Ingelheim, Ceva, Elanco, Idexx, Merial and Royal Canin.
The show follows veterinary surgeons and nurses going about their day-to-day work, consulting and operating on a variety of cases from the routine to the extraordinary.
The ten-episode series stars Cat Henstridge, who many will be familiar with for her social media posts as 'Cat the Vet', and her husband Dave Hough who is the Clinic Director at the practice.
Cat said: "I know from the reactions I get on my website and social media channels that there is a huge level of interest in what we do, and the TV programme will help to bring those real-life stories directly to a younger audience, as well as offering exclusive behind the scenes access to everything that happens in our busy veterinary practice."
Dave added: "We are thrilled to be showcasing the fantastic work of our dedicated and talented team. What we see every day is so varied, and we are driven by our love of pets and the ability to help heal them. It’s a real delight to think that our work will be seen on television, and hopefully inspire the next generation of vets, nurses and support staff to work in this really rewarding profession."
The webinars are presented by Dr Rachel Dean BVMS PhD MSc(EBHC) DSAM(fel) SFHEA MRCVS, Clinical Associate Professor in Feline Medicine at the School of Veterinary Medicine and Science, Nottingham and founding Director of the Centre for Evidence-Based Veterinary Medicine (pictured right).
The first webinar kicks off at 8:00pm on Tuesday 17th April, when Rachel will give an introduction to EBVM and reminder of why it is so important in practice.
The second session will follow on 24th April, when Rachel will explain how to find and evaluate evidence, and how you can use it to underpin your clinical decision-making process in practice.
In the final webinar, on Tuesday 1st May, Rachel will use a nutritional case study to demonstrate the real-world clinical application of EBVM concepts.
Lee Danks BVSc BVMS MRCVS, Royal Canin’s Scientific Affairs Manager said: "In this three-part series we hope to summarise EBVM for those unaccustomed to this approach and review how it can help improve our clinical decision-making in practice.
"By taking a step by step approach and delivering 'easily-digestible' lessons over three weeks we hope to answer as many questions vets and nurses have as possible with some highly applicable content from Rachel Dean."
For more information and to register, visit https://vetportal.royalcanin.co.uk/cpd/webinar2018/
Protexin says Pro-Kolin Advanced contains beneficial micro-organisms, several prebiotic sources, an optimal level of a dual-source binding agent and soothing fibres to support gastrointestinal function.
The company also says that in a study involving 148 dogs, Pro-Kolin Advanced significantly improved clinical outcome compared to a placebo1.
Protexin Veterinary Director, James Kyffin, said: "Pro-Kolin Advanced represents an exciting development for Protexin Veterinary and fits in perfectly with our ethos to produce innovative, research-based products of the highest quality for pets.
"It is the first product of its kind to be supported by a randomised, controlled clinical trial that was undertaken in first opinion veterinary practices across the UK and Ireland.
"Not only are we pleased to be able to offer veterinary surgeons with an evidence-based option for the management of acute gastrointestinal disturbances, but also a very palatable formulation that was readily accepted by 92% of the dogs in the study."
Pro-Kolin Advanced is available in 15ml, 30ml and 60ml syringes for dogs and 15ml syringes for cats. The flavourings used in the product contain no proteins or common allergens so Pro-Kolin Advanced can be used in animals with known hypersensitivities.
Reference
Animal Friends is launching a pilot programme through which its customers will be able to check their pets' symptoms, get advice on treatment or find out if they need to visit a vet clinic on Joii.
Paul Hallett, co-founder of Vet-AI said: "Animal Friends is a perfect partner for Vet-AI, not only do we share common goals around animal welfare and the profession as a whole, but strategically we are both laser focused on the customer. In the coming few years we will support their customers by providing them with 24 hour expert-led care, at the click of a button. This will drive our business forward, helping us reach more pet owners and improve the care their pets receive."
Wes Pearson, Managing Director of Animal Friends said: "This partnership demonstrates our commitment to provide our pet parents with innovative options to ensure their pet receives the best care. Being able to access professional advice from the comfort of their own home and at a time that suits them can dramatically reduce stress for both the pet and the pet parent. We are excited to be working with Vet-AI and believe that the Joii app will bring expert knowledge and extra peace of mind to our customers."
Oh no, not another company talking about 'pet parents'. Is it just me, or is it not rather patronising?
The company says industry estimates are that 12 million accessible breeding ewes (91%) are not vaccinated against enzootic abortion in the UK, and that this should concern all practitioners with sheep clients.
Any flock with an abortion rate of over 2% could, it says, be suffering from the disease, and at a cost of £85 per aborted ewe, those are losses producers can ill-afford to ignore.
Stephenie Clarke from Ceva said: "Abortion remains one of the most significant reasons for loss in sheep flocks and an abortion storm can lead to crippling results on farm.
"Enzootic abortion caused by C. abortus remains the main cause of ovine abortion in the UK1 and once in a flock, takes time to control as exposed ewes can become latently infected."
Assure Ewe is a subsidised blood testing scheme open to all flocks with 50 or more breeding ewes. In contrast to other schemes, evidence of an abortion does not need to have taken place.
Blood samples should be collected from six ewes, with full farm and vet details also supplied. Upon results, Ceva says it will share information with the participating veterinary surgeon to discuss with the farmer.
Stephenie added: "Assure Ewe is a very user-friendly, simple scheme that will help facilitate conversations between vets and farmers while, at the same time, providing useful testing information to vets. Ceva encourages evidence based veterinary decisions, and this is just one example of such an initiative."
If C. abortus is identified in a flock, a veterinary-devised plan combining vaccination with Cevac Chlamydia, biosecurity and only purchasing stock from accredited flocks will assist disease control and eventual eradication.
For further information about the scheme, contact your Ceva territory manager.
Merial Animal Health has announced that it has purchased the the anti-inflammatory treatment for lameness in horses, Hyonate® (sodium hyaluronate), from Bayer.
Merial's equine marketing and technical manager, Louise Radford MRCVS said: "Hyonate is an established treatment of lameness in horses due to non-infectious inflammation of joints, using both intra-articular (IA) and intravenous (IV) injection.
"The beneficial effects of HA supplementation are attributable to the anti-inflammatory effects, improvement in viscoelastic properties of the synovial fluid, and interaction with the synovial membrane affecting pain transmission and joint metabolism¹."
For more information telephone Customer Support on 0870 6000123 or contact your local Merial Equine Specialist.
The charity-run Vetlife helpline, which offers 24/7 confidential support, says it had 2775 contacts from members of the profession last year, up 160% on the previous year.
Vetlife Operations Manager Joanne Driver said: "We’re aware that for many the impact of seasonal work pressures for vet practices and the stresses of the already hectic Christmas period do not simply disappear when January arrives. When paired with mental health issues or personal worries, it can continue to feel overwhelming.
Vetlife helpline is a safe place to talk for those who are struggling, and our volunteers can signpost callers to resources and our health and financial services.
"It can be hard to spot colleagues who are struggling or to find ways to offer the help they need. By supporting Vetlife you can help us ensure there is a friendly anonymous voice at the end of the phone or via email for everyone in the veterinary community who needs it. Vetlife is largely run by volunteers and we rely on your support and donations to keep the services running.
"Please make a meaningful resolution this year and support Vetlife through a donation, by becoming a member or by joining as a volunteer."
If you would like to support Vetlife, there are a number of ways to help:
DonateAs a registered independent charity, Vetlife relies on the generosity of the people in the veterinary community and veterinary organisations to be able to continue its work. The simplest way to donate is online at: www.vetlife.org.uk/support-us/donate/
VolunteerVetlife is almost entirely managed and run by its volunteers. To learn more about volunteering for Vetlife Helpline or as an Area Representative, visit www.vetlife.org.uk/support-us/volunteer/
Become a Vetlife MemberVetlife members are an essential link with the veterinary community, helping it to make sure everyone knows about the support services that it offers. You must be a veterinary surgeon to become a Vetlife member. You can complete the Vetlife membership form at: vetlife.org.uk/support-us/become-a-vetlife-member/
Vetlife Helpline is available on: 0303 040 2551 or email via www.vetlife.org.uk
The BCVSp says the aim of its proposal is to identify practices that offer a multi-disciplinary referral service, to incorporate standards for specialist care and to define training, veterinary and nursing qualifications, behaviours and facilities which optimise management of cases with complex problems and those requiring advanced diagnostic and/or therapeutic approaches.
Terry Emmerson Hospital Director at North Downs Specialist Referrals and BCVSp trustee said: "Increasing numbers of veterinary graduates are choosing to pursue training leading to post-graduate diplomas and RCVS recognition as Specialists.
"Many vets and nurses are working in groups that allow a multidisciplinary approach to be offered to animals with complex problems. We hope that we can devise a new accreditation strand to give the animal-owning public the ability to distinguish multidisciplinary specialist hospitals from general veterinary hospitals in order to make informed choices regarding the veterinary care they wish to access for their animals."
BCVSp has proposed that prior to entry into the new strand, VSH(M)s would first be required to meet the Core, GP and Veterinary Hospital requirements in all of the modules (Small Animal or Equine as appropriate) and achieve Awards Points at Outstanding level in the relevant modules. BCVSp has put forward an outline plan which is currently being considered by the PSG in which VSH(M)s will be required to offer a minimum number of services but there will also be scope for individual units to highlight particular areas of expertise.
Celia Marr, BCVSp Chairman said: "A key element of the strand we are working on is that each service will be led by RCVS Specialists ensuring on-going accreditation of the experience and expertise within the range of services that together underpin a multidisciplinary approach to case management. We have consulted widely amongst our members to reach consensus on the standards each specialist service should be aiming for."
She added: "We hope to work together with the PSG to develop an accreditation within this strand over the next few years, however working through the current PSS modules to Awards Points level is not easy. Specialist-staffed hospitals aiming for the multidisciplinary strand will need to start planning their approach as soon as possible."
Mandisa Greene, Chair of the Practice Standards Group, said: "The RCVS Practice Standards Group welcomes BCSVp’s proposal and the passion of the group for developing this new accreditation level. Both the PSG and the RCVS Standards Committee will be working with the BCVSp to consider the proposal's feasibility, how the accreditation level might be achieved, potential levels of interest and other criteria in the coming months. It is critical that specific criteria which BCVSp and the RCVS Practice Standards Group develop together are clear, transparent and testable."
Photo: Newmarket Equine Hospital
Felpreva is the first spot-on parasiticide for cats that covers tapeworms in addition to other endoparasites including gastrointestinal roundworms and lungworms, and ectoparasites (fleas, ticks and mites) for up to three months with a single dose.
It is licensed for treatment of cats with, or at risk from, mixed parasitic infestations/infections, including:
Matthieu Frechin, Vetoquinol CEO, said: “Marketing authorisation is a pivotal achievement for both Vetoquinol and Felpreva.
"It is a breakthrough treatment with convenience and simplicity of use combined with long-lasting efficacy.
"We believe that Felpreva will be a real game changer for this area of veterinary medicine, demonstrating our commitment to the parasiticide market.”
It is anticipated that Felpreva will be available in Europe early in 2022.
Rominervin contains 10 mg/ml romifidine hydrochloride, equivalent to 8.76 mg romifidine, presented in a 20 ml vial.
It can be used as a sedative to facilitate handling, examination, minor surgical interventions and minor procedures or as a premedication prior to administration of injectable or inhalation anaesthetics.
Rominervin can also be used in combination with synthetic opiates such as butorphanol to provide deeper sedation or analgesia.
Dechra Brand Manager Emma Jennings said: "Rominervin is highly effective as it has a longer duration of action than other alpha-2 agonists1. It starts to work within one to two minutes with maximum sedation achieved between five and 10 minutes.
"It is yet another valuable addition in our equine anaesthesia and analgesia range that has been designed to provide vets with the therapies they need to operate successfully in day-to-day practice."
Rominervin can be used in conjunction with Dechra’s equine anaesthesia and analgesia app, designed to help veterinary professionals choose optimal anaesthetic protocols and calculate anaesthetic drug doses and administration rates.
For more information visit: www.dechra.co.uk/products/equine
BVA’s Voice of the Veterinary Profession survey panel, which polls over 1,000 UK vets, highlighted that many vets support the higher welfare standards of British farming, with 9 out of 10 vets saying they would be more likely to buy food if it was labelled as British or locally sourced. Over three quarters of vets said that they would be more likely to buy free-range (77%) or food that carried a Farm Assurance Scheme label (over 50% for Red Tractor and RSPCA Assured; formerly known as Freedom Food).
BVA President Sean Wensley encouraged consumers to check labels as the warmer weather sees BBQs and picnics take centre stage in gatherings of families and friends. He said: "Animal welfare should be a paramount consideration whether we’re thinking about purchasing pets or the food we eat. For vets it’s a top priority that the animals we rear for food have a good life and a humane death.
"Vets are not alone in caring about where their food comes from. To support high standards of animal welfare, all of us can vote for good animal health and welfare through our thoughtful meat, fish, and dairy purchases and send a strong message to food producers and retailers this summer."
BVA’s Voice of the Veterinary Profession survey panel also revealed that 9 out of 10 vets would be less likely to buy meat or fish if it was labelled as not stunned prior to slaughter.
BVA is leading a campaign to end slaughter without pre-stunning for animal welfare reasons and calling for better labelling of food to help consumers make pro-animal welfare choices.
To find out more about BVA’s campaign to end non-stun slaughter, visit: http://www.bva.co.uk/News-campaigns-and-policy/Campaigns/An-end-to-non-stun-slaughter
Image: CC BY-SA 2.0 cyclonebill